Clinical trial

Clinical Relationship Between Vitamin D-mediated Th17 and Treg Cells and Parkinson's Disease

NCT06539260

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Vitamin D Normalized identity: vitamin DView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Clinical Relationship Between Vitamin D-mediated Th17 and Treg Cells and Parkinson's Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: EARLY_PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-01-01

PhaseEARLY_PHASE1

Conditions

Neurologyunresolved

Immunologyunresolved

Interventions

Vitamin DDRUG · verified · RxNorm: vitamin D

PlaceboDRUG

Sponsors & collaborators

Suzhou Municipal Hospital of Anhui Provincelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06539260 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.